Furthermore, the adenosine-generating ectoenzymes CD39 and CD73 are regulated by HIF1A and have been shown to promote tumor growth, invasiveness, and metastatic potential, resulting in poor clinical outcomes (8, 9, 16–20, 28, 29, 35, 36, 42). This evidence concerns the gene ENTPD1 and neoplasm.